Advertisement

Topics

Human medicines European public assessment report (EPAR): Biktarvy, bictegravir / emtricitabine / tenofovir alafenamide, Revision: 0, Authorised

12:00 EDT 22 Jun 2018 | European Medicines Agency

Original Article: Human medicines European public assessment report (EPAR): Biktarvy, bictegravir / emtricitabine / tenofovir alafenamide, Revision: 0, Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Biktarvy, bictegravir / emtricitabine / tenofovir alafenamide, Revision: 0, Authorised"

Advertisement
Quick Search
Advertisement
Advertisement